Metabolix, Inc.

YTENQ Basic Materials Agricultural Inputs

Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN
Market cap
$1.5M
P/E
0.0×
Fwd P/E
−0.1×
Dividend yield
—
F-score
2/9
Altman Z
−161.45
Beneish M
n/a
Dividend safety
n/a
Jun '24 Mar '24 Dec '23 Sep '23 Older periods
ROE
449.55% 1,211.52% (1,508.09%) (380.77%)

+8 more TTM periods

Piotroski F-Score
— 3 — —
ROA
(287.44%) (274.51%) (241.08%) (167.40%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
210.54% 365.14% 495.54% (483,066.67%)
Average Days of Receivables
0.00 0.00 — —
Free Cash Flow per Share
(9.03) (16.00) (30.53) (30.54)
Free Cash Flow
(5.80) (8.30) (10.11) (11.44)
Capital Expenditures
— — (0.05) (0.03)
Other line items
Cash ROIC
105.34% 483.92% 714.77% (356.65%)
Accounts Receivable Turnover
0.00 0.00 — —
Accounts Payable Turnover
0.00 0.00 0.00 2.04
Inventory Turnover
— — — 0.00
Average Days of Payables
0.00 0.00 0.00 280.94
Days of Inventory on Hand
— — — 0.00
Tax Rate
0.00 0.00 0.00 0.01
Research and Development Expense of Revenue
800.33% 1,348.92% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
687.18% 1,044.80% 0.00% 0.00%
Share Based Compensation of Revenue
168.12% 279.39% 0.00% 0.00%
Operating CF/Net income
0.46 0.63 0.70 0.79
Depreciation/Fixed assets
0.63 0.59 0.53 0.48
Capex/Depreciation
0.00 0.00 (0.16) (0.09)
Revenue per Share
1.40 1.08 0.00 0.00
Operating CF per Share
(9.03) (16.00) (30.39) (30.47)
Capex per Share
0.00 0.00 (0.14) (0.07)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates